EMILY JORDAN: Open Payments
NPI 1407624919 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 37 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $486 · 2025 $894
Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $195 |
| Amgen Inc. | 5 | $110 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Aurinia Pharma U.S., Inc. | 3 | $64 |
| Travere Therapeutics, Inc. | 2 | $52 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Alexion Pharmaceuticals, Inc. | 2 | $50 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
Products named: FARXIGA, KRYSTEXXA, BENLYSTA, Kerendia, LUPKYNIS, PURIFIED CORTROPHIN GEL, JARDIANCE, ACTHAR.
Industry payments across NC — which companies pay providers there.
